ArticleOncoTargets and therapy2024

Prolonged Clinical Benefit with Futibatinib in a Patient with FGFR Inhibitor-Pretreated

Paolo D d'Arienzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.